![]() |
Open for inclusion |
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Trial of Crenolanib in Subjects with Advanced or Metastatic Gastrointestinal Stromal Tumors with a D842V Mutation in the PDGFRA GeneCancer type: Sarcoma Phase: II Principal Investigator: Hall Sundby Kirsten Country: NO Keywords: Norway, Oslo, GIST, crenolanib Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02847429?term=ARO-012&rank=1 |